Regular ArticleSurvival among U.S. Women with Invasive Epithelial Ovarian Cancer
References (24)
- et al.
The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer
Gynecol Oncol
(1995) - et al.
Trends in United States Ovarian Cancer Mortality, 1979–1995
Obstet Gynecol
(1999) - et al.
Ovarian cancer in the elderly: an analysis of Surveillance Epidemiology, and End Results Program data
Am J Obstet Gynecol
(1986) - et al.
Cancer statistics, 2001
CA Cancer J Clin
(2001) - et al.
SEER Cancer Statistics Review
(2001) FIGO stage, histologic grade, age and race as prognostic factors in determining survival in cancers of the female gynecological system: an analysis of 1973–1987 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina
Semin Surg Oncol
(1994)- et al.
The National Cancer Data Base Report on ovarian cancer
Cancer
(1995) - et al.
The National Cancer Data Base Report on malignant epithelial ovarian carcinoma in African-American women
Cancer
(1997) Prognostic factors in ovarian cancer
Semin Oncol
(1998)- et al.
Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients
Br J Obstet Gyneacol
(1999)
Management of borderline tumors of the ovary: state of the art
Semin Oncol
Cited by (137)
Current status of hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer in the United States
2020, Gynecologic OncologyCitation Excerpt :When grouping non-white racial groups together, there was not a difference in rates of HIPEC between non-White and White ovarian cancer patients. Prior studies have shown that Black women are less likely to receive surgery and chemotherapy and more often treated with chemotherapy alone, with one study showing that Black ovarian cancer patients had 40% higher odds of not having an operative procedure compared to White patients [25–28]. Racial disparities in adoption of novel treatment strategies are improtant to track and will need to be reported once numbers reach a threshold that protect patient privacy.
Appendiceal mucinous neoplasm mimics ovarian tumors: Challenges for preoperative and intraoperative diagnosis and clinical implication
2019, European Journal of Surgical OncologyDisparities in treatment and survival among elderly ovarian cancer patients
2018, Gynecologic OncologyConstruction of a Prediction Model of Cancer-Specific Survival after Ovarian Clear Cell Carcinoma Surgery
2024, Clinical and Experimental Obstetrics and GynecologyClinicopathological and Oncological Outcomes of Borderline Mucinous Tumours of Ovary: a Large Case Series
2023, Indian Journal of Surgical Oncology
- 1
To whom correspondence and reprint requests should be addressed at Department of Health Research and Policy, HRP Redwood Building, Room T213C, Stanford University School of Medicine, Stanford, CA 94305-5405. Fax: (650) 725-6951. E-mail: [email protected].